S

Stille AB
STO:STIL

Watchlist Manager
Stille AB
STO:STIL
Watchlist
Price: 203 SEK -1.93% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Stille AB?
Write Note

Stille AB
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stille AB
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
S
Stille AB
STO:STIL
Common Shares Outstanding
kr9m
CAGR 3-Years
21%
CAGR 5-Years
13%
CAGR 10-Years
6%
Elekta AB (publ)
STO:EKTA B
Common Shares Outstanding
kr382.1m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Common Shares Outstanding
kr51m
CAGR 3-Years
0%
CAGR 5-Years
9%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Common Shares Outstanding
kr23.9m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Getinge AB
STO:GETI B
Common Shares Outstanding
kr272.4m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Common Shares Outstanding
kr272.4m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
No Stocks Found

Stille AB
Glance View

Market Cap
1.8B SEK
Industry
Health Care

Stille AB engages in the development and sale of medical equipment. The company is headquartered in Torshaella, Sodermanlands. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.

STIL Intrinsic Value
286.89 SEK
Undervaluation 29%
Intrinsic Value
Price
S

See Also

What is Stille AB's Common Shares Outstanding?
Common Shares Outstanding
9m SEK

Based on the financial report for Sep 30, 2024, Stille AB's Common Shares Outstanding amounts to 9m SEK.

What is Stille AB's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
6%

Over the last year, the Common Shares Outstanding growth was 79%. The average annual Common Shares Outstanding growth rates for Stille AB have been 21% over the past three years , 13% over the past five years , and 6% over the past ten years .

Back to Top